Caitong International Asset Management’s Rallybio RLYB Stock Holding History

Caitong International Asset Management’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.94K	Buy	+434	New	+$5.58K	﹤0.01%	1233

Other funds holding RLYB

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Caitong International Asset Management's RLYB Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Rallybio (RLYB) in Q2 2026: 434 shares worth $6.94K. The stake represents ﹤0.01% of the portfolio and ranks #1233 among its holdings.

37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

Caitong International Asset Management held 434 shares of Rallybio worth $6.94K as of Q2 2026.
Rallybio was a new Caitong International Asset Management position in Q2 2026.
Rallybio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1233 holding.
37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.